Phaseline

Companies › Ningbo Rongan Biological Pharmaceutical

Ningbo Rongan Biological Pharmaceutical: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Infectious disease.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Freeze-dried Human Rabies Vaccine (Human Diploid Cell)
Rabies virus inactivated vaccine
–Phase 1Rabies–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07021703Freeze-dried Human Rabies Vaccine (Human Diploid Cell)Phase 1RabiesInfectious diseaseJul 2025

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.